besr cardiologist in Telangana

Dr. A. Sreenivas Kumar


040 - 4345 4345 info@www.prathimahospitals.com

MD, DM, FACC (USA)
Consultant Cardiologist

AWARDS &  MEMBERSHIPS

  • State II Rank in Andhra Pradesh MBBS Entrance Examination
  • S.R. Rao Research Award for best thesis in M.D. General Medicine – “A study of clinical profile of cases of Sickle cell disorder in adults”
  • Founder Editor of National Medical Journal “Post Graduate Medical Clinics of Osmania”
  • Selected as reviewer for International Journal “Catheterization & Cardiovascular Diagnosis” in 1998
  • President for 2009-10, Cardiological Society of India, AP Chapter
  • Executive Committee member, Cardiological Society of India 2007-09
  • Faculty for training Interventional Cardiologists from USA for Transseptal puncture technique training – St Judes Co. Initiative to train Interventional & EP Cardiologists of USA
  • Faculty for SING LIVE Course in Singapore in 2006-08
  • Faculty for CIT – China Interventional Therapeutics-2009
  • Faculty for CCT – Kobe, Japan-2009
  • Faculty for Angioplasty Summit, Seol, Korea-2010
  • Faculty for TCT, USA – 2011, 2012
  • Live Case Operator for Procedure Demonstration to TCT, USA 2012
  • Programme Director & Founder of ACVS (Advance CardioVascular Solutions) India National Conference
  • Scientific advisor and Product concepts & device analyzer for Relysis India, Medtronic & Boston Scientific. India
  • Scientific Advisory Member – Indian Heart Journal

ACCOMPLISHMENTS

  • Principal Investigator for Nephric – II Study – A Randomized Comparison of Iapamiro vs. Iopamidal in Diabetic Renal Insufficiency patients – Sponsored by GE Health Care. – Appreciated as World’s leading recruiter for enrolling maximum no of patients
  • Co-Investigator – a multinational, multicentre, randomized, parallel group, Double-blind study to assess the efficacy and safety of 1 mg, 5 mg and 20 mg tid of oral sildenafil in the treatment of Subjects aged 18 years and over with pulmonary arterial Hypertension (PAH) – A Multicentre PAH study sponsored by Pfizer Int. Ltd. – Leading recruiters in the world
  • Principal Investigator – Spirit Women Clinical Evaluation: A Clinical Evaluation of the Xience – V Everolimus eluting coronary stent system in the treatment of women with denovo coronary artery lesion (single arm study protocol) – Leading recruiter in the world
  • Principal Investigator – AMI – Stem cell study – A Randomized, double blind Multicentric, Placebo controlled, Single dose , Phase-II Study assessing the safety and efficacy of Intravenous ex vivo cultured adult allogenic mesenchymal stem cells in patients with STEMI – Sponsored by STEMPEUTICS Research Ltd
  • Co-Investigator – ART (Arterial Revascularisation Trial) ART is a multi-centre, international, randomized trial evaluating whether the use of both mammary arteries during coronary artery bypass grafting (CABG) improves survival, and reduces the chance of recurrent chest pain and/or the need for further intervention (including surgery) compared to using one mammary artery. ART is supported by grants from the Medical Research Council and the British Heart Foundation
  • National Lead Investigator – Msure – Sirolimus Eluting Co. Chromium Stent – Clinical & Angiographic Follow up Study